[1]潘谊,吴辉坤.基于毒痰瘀虚理论探讨中药复方对肝癌血管生成的影响[J].西部中医药,2023,36(03):24-27.[doi:10.12174/j.issn.2096-9600.2023.03.05]
　PAN Yi,WU Huikun.The Effects of Herbal Compound on Hepatocellular Carcinoma Angiogenesis Based on the Theory of Toxin/Phlegm/Stagnation-induced Deficiency[J].Western Journal of Traditional Chinese Medicine,2023,36(03):24-27.[doi:10.12174/j.issn.2096-9600.2023.03.05]
点击复制

基于毒痰瘀虚理论探讨中药复方对肝癌血管生成的影响
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
36
期数:
2023年03期
页码:
24-27
栏目:
出版日期:
2023-03-14

文章信息/Info

Title:
The Effects of Herbal Compound on Hepatocellular Carcinoma Angiogenesis Based on the Theory of Toxin/Phlegm/Stagnation-induced Deficiency
作者:
潘谊1, 吴辉坤1,2,3
1.湖北中医药大学，湖北 武汉 430065
2.湖北省中医药研究院，湖北 武汉 430074
3.湖北省中医院，湖北 武汉 430061
Author(s):
PAN Yi1, WU Huikun1,2,3
1.Hubei University of Chinese Medicine, Wuhan 430065, China
2.Hubei Research Institute of Traditional Chinese Medicine, Wuhan 430074, China
3.Hubei Provincial Hospital of TCM, Wuhan 430061, China
关键词:
肝癌; 血管生成; 毒痰瘀虚理论; 中药复方
Keywords:
hepatocellular carcinoma; angiogenesis; the theory of deficiency induced by toxin;  phlegm and stagnation; herbal compound
分类号:
R735.7
DOI:
10.12174/j.issn.2096-9600.2023.03.05
文献标志码:
A
摘要:
目的基于毒痰瘀虚理论探讨中药复方对肝癌血管生成的影响。 方法制备Wistar大鼠含药血清，以含药血清体外培养HepG2细胞，并分为空白组、中药复方组（毒痰瘀脾肾虚方、毒痰瘀脾虚方、毒痰瘀肾虚方、毒痰瘀肾阳虚方、毒痰瘀肾阴虚方、毒痰瘀方）；采用酶联免疫吸附试验(Enzyme-linked immunosorbent assay，ELISA)法检测细胞培养上清液中血管内皮生长因子(vascular endothelial growth factor，VEGF)表达；采用HepG2肝癌移植性肿瘤模型方法于小鼠腋下接种HepG2肝癌细胞株，免疫组织化学法检测肿瘤微血管密度（MVD）。 结果与空白组比较，中药复方组可降低肝癌HepG2细胞中VEGF表达（P＜0.01），其中毒痰瘀脾肾虚方（全方）组最明显。而除全方组外，其余各中药复方组对肝癌HepG2细胞中VEGF表达的影响作用相当，差异无统计学意义（P＞0.05）。与空白组相比，中药复方组均能降低肝癌HepG2小鼠肿瘤组织中MVD，毒痰瘀脾肾虚方组最明显，差异具有统计学意义（P＜0.05）；毒痰瘀组与毒痰瘀脾肾虚方组相比差异有统计学意义（P＜0.05）。 结论基于毒痰瘀虚理论组方的中药复方具有抑制肝癌血管生成的作用。
Abstract:
ObjectiveTo discuss the influence of herbal compound on hepatocellular carcinoma (HCC) angiogenesis on the foundation of the theory of deficiency induced by toxin, phlegm and stagnation. MethodsAfter preparing drug-containing serum from Wistar rats, HepG2 cells were cultured in vitro with drug-containing serum, divided into the blank group and herbal compound groups [toxin/phlegm/stagnation-induced spleen-kidney deficiency prescription (SKD), toxin/phlegm/stagnation-induced spleen deficiency prescription (SD), toxin/phlegm/stagnation-induced kidney deficiency prescription (KD), toxin/phlegm/stagnation-induced kidney Yang deficiency prescription (KYAD), toxin/phlegm/stagnation-induced kidney Yin deficiency prescription (KYID), toxin, phlegm, stagnation prescription (TPS)]; ELISA method was adopted to detect the expressions of VEGF in the cell liquid supernatant; immunohistochemical method was utilized to measure tumor microvessel density (MVD) by using HepG2 hepatoma xenograft tumor model via the axillary inoculation of HepG2 hepatoma cell line. ResultsCompared with the blank group, herbal compound groups could lower the expressions of VEGF in HepG2 cells (P<0.01), among them, the groups of whole prescription showed the obvious effects. However, except the group of SKD (whole prescription), the rest of herbal compound groups showed equivalent effects on， SD the expressions of VEGF in HepG2 cells, and the difference had no statistical meaning (P>0.05). Compared with the blank group, herbal compound groups could reduce MVD in tumor tissue of HCC HepG2 mice, SKD presenting the most obvious effects, and the difference had statistical meaning (P<0.05); the difference had statistical meaning when TPS was compared with SKD (P>0.05). ConclusionHerbal compound formed by the theory of toxin/phlegm/stagnation-induced deficiency could inhibit HCC angiogenesis.

相似文献/References:

[1]曹军英.纽曼护理对原发性肝癌介入治疗患者焦虑和生活质量的影响[J].西部中医药,2015,28(04):140.
[2]邹勇,殷子斐,程彬彬,等.世界三大饮品预防肝癌研究进展[J].西部中医药,2018,31(05):131.
　ZOU Yong,YIN Zifei,CHENG Binbin,et al.Research Progress of Three Drinks in the Prevention of Liver Cancer[J].Western Journal of Traditional Chinese Medicine,2018,31(03):131.
[3]杨军民,何耀辉,马宝梅.大黄?虫丸联合化疗治疗原发性肝癌35例[J].西部中医药,2018,31(10):83.
　YANG Junmin,HE Yaohui,MA Baomei.DaHuang ZheChong Pills Combined with Chemotherapy in Treating 35 Cases of Primary Liver Cancer[J].Western Journal of Traditional Chinese Medicine,2018,31(03):83.
[4]刘玉华,王敏△.微波消融治疗肝癌的围手术期护理[J].西部中医药,2017,30(04):122.
　LIU Yuhua,WANG Min.Perioperative Care for the Patients with Liver Cancer Treated by Microwave Ablation[J].Western Journal of Traditional Chinese Medicine,2017,30(03):122.
[5]陈艳,童金龙,郑勤.团体认知行为疗法对青年肝癌患者心理状况与生活质量的影响[J].西部中医药,2017,30(11):115.
　CHEN Yan,TONG Jinlong,ZHENG Qin.Effects of Group Cognitive-behavioral Therapy on Psychological Status and Quality of Life of Young Patients with Hepatic Carcinoma[J].Western Journal of Traditional Chinese Medicine,2017,30(03):115.
[6]曲骞,吴煜△.吴煜教授疏肝健脾法治疗肝癌经验探析[J].西部中医药,2018,31(06):40.
　QU Qian,WU Yu.Analysis of Professor Wu Yu′s Experience of Treating Liver Cancer by Liver-soothing Spleen-invigorating Method[J].Western Journal of Traditional Chinese Medicine,2018,31(03):40.
[7]赵阳.紫草素对荷肝癌大鼠免疫功能的影响[J].西部中医药,2018,31(09):26.
　ZHAO Yang.Effects of Shikonin on Immunologic Function of the Rats Suffering Liver Cancer[J].Western Journal of Traditional Chinese Medicine,2018,31(03):26.
[8]林泳欣,王昌俊△.健脾化瘀方对肝癌HepG-2细胞生理活性的影响[J].西部中医药,2018,31(11):11.
　LIN Yongxin,WANG Changjun.Effects of Spleen-invigorating Stasis-eliminating Prescription on Physiological Activity of HepG-2 Cells in Liver Cancer[J].Western Journal of Traditional Chinese Medicine,2018,31(03):11.
[9]黄常江,刘俊波,廖天华,等.止痛膏联合三阶梯止痛原则治疗肝癌疼痛60例临床观察[J].西部中医药,2018,31(12):98.
　HUANG Changjiang,LIU Junbo,LIAO Tianhua,et al.Clinical Observation on Pain-relieving Ointment and Three-step Pain-relieving Principles in Treating 60 Cases of Liver Cancer Pain[J].Western Journal of Traditional Chinese Medicine,2018,31(03):98.
[10]王海明,孙欢,陈格格,等.氩氦刀冷冻消融术联合复方红豆杉胶囊治疗原发性肝癌临床观察[J].西部中医药,2019,32(01):89.
　WANG Haiming,SUN Huan,CHEN Gege,et al.Clinical Observation on Treatment for Primary Hepatic Cancer by Argon-helium Cryoablation and Compound HongDouShan Capsules[J].Western Journal of Traditional Chinese Medicine,2019,32(03):89.
[11]谭松,侯爱画,于春凤,等.愈肝散结颗粒对晚期肝癌患者血清VEGF及HIF-1α的影响[J].西部中医药,2019,32(01):5.
　TAN Song,HOU Aihua,YU Chunfeng,et al.Effects of YuGan SanJie Granules on the Expression of VEGF and HIF-1α of the Patients Suffering Advanced Hepatoma[J].Western Journal of Traditional Chinese Medicine,2019,32(03):5.

备注/Memo

备注/Memo:
潘谊（1992—），女，在读硕士研究生。研究方向：结石及肝胆病的中医药防治。国家中医药管理局国家中医临床研究基地业务建设科研专项课题（JDZX2015177）。
更新日期/Last Update: 2023-03-15